In a recent interview with Al Ryan TV, Dr. Latifa Al Khayat, an associate at the Department of Pharmacy and Drug Control at the Ministry of Public Health in Qatar, shed light on the country's stringent regulations governing medicine imports. These rules, she explained, are meticulously designed to safeguard patient safety and minimize pharmaceutical waste, reflecting a proactive approach to healthcare management.
One of the key requirements for imported medicines is that they must have at least two-thirds of their shelf life remaining at the time of entry into Qatar. This condition, Dr. Al Khayat emphasized, is primarily regulatory in nature, aiming to ensure that medicines have sufficient time to be distributed, dispensed, and utilized effectively within the country. By preventing the entry of medicines close to expiry, this rule minimizes waste and guarantees that patients receive safe and effective treatments.
The time required for import procedures, customs clearance, and distribution across healthcare facilities necessitates a sufficient remaining shelf life to maintain quality and usability. Dr. Al Khayat highlighted the comprehensive system in place to ensure the quality and safety of medicines, which begins even before shipments arrive in the country. Prior import permits are required based on assessed national needs and demand forecasts, and once shipments are prepared, they undergo a release authorization process, including verifying compliance with regulatory standards both before and upon arrival.
Addressing concerns about medicines nearing their expiration dates, Dr. Al Khayat clarified that the issue is largely logistical rather than directly harmful to patients. Medicines with short remaining shelf lives may not be used in time, increasing the risk of wastage and placing strain on supply chains. This, in turn, can affect the consistent availability of medicines in the local market. The goal, she added, is to maintain a stable supply chain and ensure that patients have access to medicines for a reasonable duration, reducing the need for frequent visits to healthcare facilities.
These regulatory measures are continuously evaluated through ongoing market studies and assessments of drug availability, including monitoring shortages and urgent needs. This dynamic approach allows authorities to respond effectively to evolving healthcare demands. Dr. Al Khayat's insights underscore the importance of such regulations in maintaining a robust healthcare system, emphasizing the need for a proactive approach to medicine management to ensure patient safety and minimize waste.
